Here are relevant reports on : cord-blood-banking-market
-
Multifactor Authentication Market by Model (Two-, Three-, Four-, and Five-Factor), Application (Banking and Finance, Government, Military and Defense, Commercial Security, Consumer Electronics, Healthcare), and Geography - Global Forecast to 2022
The multifactor authentication (MFA) market is estimated to grow from USD 5.2 billion in 2016 to USD 12.5 billion by 2022, growing at a CAGR of 15.5% during the forecast period. The factors that will drive the MFA market include increase in data breaches and cyber–attacks, stringent regulations and the growing pressure of data security compliances, and the growing adoption of BYOD concept among enterprises.Some of the major players in the multifactor authentication market are Safran (France), Gemalto NV (the Netherlands), NEC Corporation (Japan), 3M (US), CA Technologies (US), Fujitsu (Japan), VASCO Data Security International Inc. (US), HID Global Corporation/ASSA ABLOY AB (Sweden), RSA Security LLC (US), Suprema HQ Inc. (South Korea), and Crossmatch (US).
- Published: May 2017
- Price: $ 4950
- TOC Available:
-
COVID-19 Impact on Fingerprint Sensor Market by Technology (Capacitive, Optical, Thermal and Ultrasonic), Application (Consumer Electronics, Banking & Finance, Travel & Immigration and Government & Law Enforcement) and Region - Global Forecast to 2025
The COVID-19 Impact on Fingerprint Sensor Market is expected to grow from USD 3.0 billion in 2020 to USD 6.0 billion by 2025, at a CAGR of 15.2% during the forecast period. Major players in the fingerprint sensor market include Goodix (China), Fingerprint Cards (Sweden), Synaptics (US), Apple (US), IDEX Biometrics (Norway), NEXT Biometrics (Norway), Novatek Microelectronics (Taiwan), Qualcomm (US), ELAN Microelectronics (Taiwan), Japan Display (Japan), Egis Technology (Taiwan), CrucialTec (South Korea), and Q Technology (China).
- Published: July 2020
- Price: $ 4950
- TOC Available:
-
Tissue Banking Market by Product (Equipment, Consumables, Media, Accessories), Services (Tissue Retrieval, Processing), Application (Drug Discovery, Therapeutic) - Global Trends & Forecast to 2019
Tissue banks facilitate the collection and banking of freshly-frozen tissue specimens. These tissues play a vital role in research into diseases and disorders, and general healthcare. They can be used to repair damaged heart muscles post-heart attacks, in skin replacement for burn victims, and in the treatment of spinal cord injuries, among other significant applications. The advancement of clinical trials and biomedical research in organ transplantation has created many prospects for tissue preservation and banking.
- Published: February 2026
- Price: $ 4950
- TOC Available:
-
Fintech as a Service Market by Type (Banking, Payments, Insurance, Lending, RegTech, Wealth Management, Digital Assets & Currencies, Cybersecurity), End User (Consumer, Banks, NBFCs, Insurance Companies, Government) - Global Forecast to 2030
The Fintech as a Service market is expected to grow from USD 470.94 billion in 2025 to USD 906.14 billion by 2030 at a compounded annual growth rate (CAGR) of 14.0% during the forecast period. The major vendors in the Fintech as a Service market are PayPal (US), Mastercard (US), Stripe (US), Fiserv (US), Block, Inc. (US), Envestnet (US), Rapyd (UK), Upstart (US), FIS (US), and Adyen (Netherlands).
- Published: August 2025
- Price: $ 4950
- TOC Available:
-
Digital Twin in Finance Market by Offering (Platforms & Solutions and Services), End-use Industry (BFSI (Banking, Financial Services, and Insurance), Manufacturing, Transportation & Logistics, Healthcare), Application and Region - Global Forecast to 2028
the digital twin in finance market size is projected to reach USD 0.5 billion by 2028, at a CAGR of 34.8% during the forecast period. The major players in the digital twin in finance market are IBM (US), Microsoft (US), Capgemini (France), SAP (Germany), Ansys (US), Altair (US), NVIDIA (US), NTT Data (Japan), Oracle (US), Deloitte (UK), Verisk (US), Cosmo Tech (France), NayaOne (UK), VSOptima (US), Merlynn (US), Piprate (Ireland), and TADA (US). These players have adopted various growth strategies, such as partnerships, agreements and collaborations, new product launches and product enhancements, and acquisitions to expand their footprint in the digital twin in finance market.
- Published: April 2023
- Price: $ 4950
- TOC Available:
-
Stem Cell Manufacturing Market by Product (Consumables, Instruments, Stem Cell Lines), Application (Research, Clinical, Cell Tissue & Banking), End User, Region (North America, Europe, APAC, Latin America, MEA) - Global Forecast to 2028
The global stem cell manufacturing market, valued at US$12.0 billion in 2022, stood at US$12.7 billion in 2023 and is projected to advance at a resilient CAGR of 11.3% from 2023 to 2028, culminating in a forecasted valuation of US$21.8 billion by the end of the period. The major factors driving the growth of this market are technological advancements in stem cell manufacturing and the increasing prevalence of genetic disorders, both of which are expected to propel market growth.
- Published: July 2023
- Price: $ 4950
- TOC Available:
-
Hepatitis Testing Market / Diagnosis Market by Disease Type (Hepatitis B, Hepatitis C, Other Hepatitis), Technology (ELISA, RDT, PCR, INAAT), End User (Hospitals, Diagnostic Laboratories, Blood Banks), and Region - Global Forecast to 2026
The global hepatitis testing market growth is primed to transition from $2.8 billion in 2021 to $3.6 billion by 2026, showcasing a strong CAGR of 4.7%. The growth of the global market is being driven by factors such as the high burden of hepatitis, increasing blood transfusion and donations, benefits of POC instruments and kits, and awareness initiatives on hepatitis.
- Published: November 2021
- Price: $ 4950
- TOC Available:
-
DNA Diagnostics Market by Product (Instruments, Reagents & Kits, Services & Software), Technology (PCR, Mass Spectroscopy, Microarrays), Application (Infectious Disease (Hepatitis, HIV, HPV), Oncology), Specimen (Blood, Urine) - Global Forecast to 2029
The global DNA diagnostics market, valued at US$12.3 billion in 2023, stood at US$13.3 billion in 2024 and is projected to advance at a resilient CAGR of 9.7% from 2024 to 2029, culminating in a forecasted valuation of US$21.2 billion by the end of the period. Growth in the market is primarily driven by the technological improvements in the DNA diagnostics industry and the growing need for personalized treatment and early disease diagnosis in developing nations. Also, the increased investments by healthcare-based companies are majorly contributing to growth of the market.
- Published: July 2024
- Price: $ 4950
- TOC Available:
-
Oncology Nutrition Market by Cancer Type (Head & Neck, Stomach & Gastrointestinal, Liver, Pancreatic, Esophageal, Lung, Breast, Blood) - Global Forecast to 2023
The global oncology nutrition market is expected to reach USD 2.21 Billion by 2023 from USD 1.46 Billion in 2018, at a CAGR of 8.7%. Factors such as shifting focus from parenteral to enteral nutrition, increasing incidence of cancer, growing demand for nutritional feeding in the homecare sector, rising number of patients being treated for malnutrition, and increasing quality of clinical research on nutritional interventions are driving the market growth. The prominent players in the oncology nutrition market are Abbott Laboratories (US), Nestle S.A. (Switzerland), Danone (France), Fresenius Kabi AG (Germany), and B. Braun Melsungen AG (Germany).
- Published: April 2018
- Price: $ 16000
- TOC Available:
-
Albumin & Creatinine Tests Market by Product (Analyzers, Cartridges (PoC, Tabletop), Dipsticks, Kits, Reagents), Type (Blood & Urine Creatinine, Urine Albumin, Glycated Albumin), Enduser (Hospital, Diagnostic & Research Labs) - Global Forecast to 2025
The global albumin & creatinine tests market growth is primed to transition from $987 million in 2020 to $2,103 million by 2025, showcasing a strong CAGR of 16.3%. The growth of this market is driven by the growing prevalence of kidney disorders and diseases, the rising adoption of POC diagnostics, and the increasing prevalence of chronic conditions.
- Published: January 2021
- Price: $ 4950
- TOC Available:
Records 31 to 40 of 50
